Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1993;24:1735-1739

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacMillan, V.
Right arrow Articles by Davis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacMillan, V.
Right arrow Articles by Davis, J.

Stroke, Vol 24, 1735-1739, Copyright © 1993 by American Heart Association


ARTICLES

Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxemic-ischemic cerebral damage

V MacMillan, D Judge, A Wiseman, D Settles, J Swain and J Davis
Department of Medicine (Neurology), University of Toronto, Ontario, Canada.

BACKGROUND AND PURPOSE: Cerebral intraventricular infusion of acidic or basic fibroblast growth factor has been shown to attenuate ischemic damage to hippocampal CA1 neurons in the gerbil. The purpose of the present study was to determine if the basic fibroblast growth factor transgenic mouse has an enhanced ability to resist the effects of severe cerebral hypoxemia-oligemia. METHODS: Mice that were transgenic for bovine basic fibroblast growth factor were exposed to right carotid artery ligation, hyperglycemia, and 20 minutes of 1% carbon monoxide. After 5 days' recovery, brains were examined for histological damage. RESULTS: Counts of CA1 neurons in the right hippocampus showed a significantly higher number of neurons per millimeter CA1 in hypoxic- ischemic transgenic mice compared with nontransgenic controls (transgenic, 260 +/- 33; nontransgenic, 151 +/- 37 neurons per millimeter CA1; P < .05). CONCLUSIONS: The results indicate that basic fibroblast growth factor transgenic mice, as judged by CA1 hippocampal neuronal survival, have an enhanced ability to resist the effects of a complex hypoxic-ischemic cerebral insult.


This article has been cited by other articles:


Home page
StrokeHome page
A. Majid, Y. Y. He, J. M. Gidday, S. S. Kaplan, E. R. Gonzales, T. S. Park, J. D. Fenstermacher, L. Wei, D. W. Choi, C. Y. Hsu, et al.
Differences in Vulnerability to Permanent Focal Cerebral Ischemia Among 3 Common Mouse Strains Editorial Comment
Stroke, November 1, 2000; 31(11): 2707 - 2714.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Alizadeh, C. M. Gelfman, S. R. Bench, and L. M. Hjelmeland
Expression and Splicing of FGF Receptor mRNAs during APRE-19 Cell Differentiation In Vitro
Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2357 - 2362.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
A. L. Boxer, H. Moreno, B. Rudy, and E. B. Ziff
FGF-2 Potentiates Ca2+-Dependent Inactivation of NMDA Receptor Currents in Hippocampal Neurons
J Neurophysiol, December 1, 1999; 82(6): 3367 - 3377.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Kamii, I. Kato, H. Kinouchi, P. H. Chan, C. J. Epstein, A. Akabane, H. Okamoto, T. Yoshimoto, and C. Y. Hsu
Amelioration of Vasospasm After Subarachnoid Hemorrhage in Transgenic Mice Overexpressing CuZn–Superoxide Dismutase • Editorial Comment
Stroke, April 1, 1999; 30(4): 867 - 872.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Bethel, J. R. Kirsch, R. C. Koehler, S. P. Finklestein, and R. J. Traystman
Intravenous Basic Fibroblast Growth Factor Decreases Brain Injury Resulting From Focal Ischemia in Cats
Stroke, March 1, 1997; 28(3): 609 - 616.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin
Biological Roles of Fibroblast Growth Factor-2
Endocr. Rev., February 1, 1997; 18(1): 26 - 45.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
H.-Y. Lin, J. Xu, D. M. Ornitz, S. Halegoua, and M. J. Hayman
The Fibroblast Growth Factor Receptor-1 Is Necessary for the Induction of Neurite Outgrowth in PC12 Cells by aFGF
J. Neurosci., August 1, 1996; 16(15): 4579 - 4587.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. H. Chan
Role of Oxidants in Ischemic Brain Damage
Stroke, June 1, 1996; 27(6): 1124 - 1129.
[Abstract] [Full Text]


Home page
StrokeHome page
R. Tanaka, Y. Miyasaka, K. Yada, T. Ohwada, and T. Kameya
Basic Fibroblast Growth Factor Increases Regional Cerebral Blood Flow and Reduces Infarct Size After Experimental Ischemia in a Rat Model
Stroke, November 1, 1995; 26(11): 2154 - 2159.
[Abstract] [Full Text]


Home page
CirculationHome page
W. Casscells
Growth Factor Therapies for Vascular Injury and Ischemia
Circulation, June 1, 1995; 91(11): 2699 - 2702.
[Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. D. Johnson, P. A. Berberian, M. Tytell, and M. G. Bond
Differential Distribution of 70-kD Heat Shock Protein in Atherosclerosis : Its Potential Role in Arterial SMC Survival
Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 27 - 36.
[Abstract] [Full Text]